Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for Xarelto (rivaroxaban) to include a 10 mg once-daily dose for reducing the risk of venous thromboembolism (VTE) after at least six months of standard anticoagulant therapy. This application is based on data from EINSTEIN CHOICE, which is the only study to find a non-vitamin K antagonist oral anticoagulant (NOAC), specifically two doses of Xarelto (10 mg and 20 mg), to be superior to aspirin in reducing the risk of recurrent VTE, with comparable rates of major bleeding.

Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF Registry presented at EHRA EUROPACE - CARDIOSTIM 2017. The findings highlight the need for screening to identify atrial fibrillation patients with no symptoms so that stroke prevention treatment can be given.

June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus catheter, the first and only re-entry ...

Mitralign Inc. announced the commencement of its SCOUT II study in Europe, with the Trialign System for the treatment of patients suffering from tricuspid regurgitation.

Shockwave Medical recently announced two milestones for its Lithoplasty System for the treatment of calcified plaque in patients with peripheral artery disease (PAD). The first patient was enrolled in the global DISRUPT PAD III clinical trial at the Medical University of Graz, Austria, and the first patient was treated in a commercial case in the United States, at Pottstown Memorial Medical Center in Pottstown, Pa.

Heart health in children will be the focus of three closely synergistic research projects and an integrated multidisciplinary training program, that are newly funded by a $3.7 million four-year grant led by Bradley S. Marino, M.D., MPP, MSC. Marino is a pediatric cardiologist from Ann & Robert H. Lurie Children’s Hospital of Chicago and professor of pediatrics and medical social sciences at Northwestern University Feinberg School of Medicine.